Employees: NN (None)Legal category: 5308Size: PMECreation date: 2012-03-09 (14 years)Status: ActiveBusiness sector: Supports juridiques de programmesLocation: PARIS (75015), Paris
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
NIH COTE D'AZUR : revenue, balance sheet and financial ratios
NIH COTE D'AZUR is a French company
founded 14 years ago,
specialized in the sector Supports juridiques de programmes.
Based in PARIS (75015),
this company of category PME
shows in 2024 a revenue of 1.5 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - NIH COTE D'AZUR (SIREN 750313561)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
Revenue
1 500 000 €
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
-391 791 €
-609 304 €
-71 801 €
141 736 €
-130 590 €
-75 436 €
-724 561 €
-25 353 €
-114 668 €
-150 774 €
EBITDA
-1 473 898 €
-33 054 €
-25 446 €
-34 720 €
-7 721 €
-23 124 €
-18 718 €
-9 499 €
-85 271 €
-123 651 €
Net margin
-26.1%
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, NIH COTE D'AZUR achieves revenue of 1.5 M€. After deducting consumption (0 €), gross margin stands at 1.5 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -1.5 M€, representing -98.3% of revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Net income is negative at -392 k€ (-26.1% of revenue), which will impact equity.
Revenue (2024)
?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production
1 500 000 €
Gross margin (2024)
?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed
1 500 000 €
EBITDA (2024)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
-1 473 898 €
EBIT (2024)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
-42 837 €
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-391 791 €
EBITDA margin (2024)
?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability 5-10% : Average < 5% : Low
-98.3%
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 41%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
0.174%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
40.668%
Cash flow / Revenue (2024)
?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates
-98.325%
Repayment capacity (2024)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
0.0
Solvency indicators evolution NIH COTE D'AZUR
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
9.516
19.125
20.86
37.78
45.731
60.094
58.845
63.571
126.84
0.174
Financial autonomy
86.936
82.655
80.346
71.099
66.852
59.853
61.361
59.363
42.907
40.668
Repayment capacity
-1.731
-4.792
-45.602
-30.863
-25.191
-89.591
-19.177
-31.048
-24.749
0.0
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
-98.325%
Sector positioning
Debt ratio
0.172024
2022
2023
2024
Q1: -81.1
Med: 0.0
Q3: 70.45
Average-16 pts over 3 years
In 2024, the debt ratio of NIH COTE D'AZUR (0.17) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
40.67%2024
2022
2023
2024
Q1: -3.67%
Med: 2.66%
Q3: 36.27%
Excellent
In 2024, the financial autonomy of NIH COTE D'AZUR (40.7%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.0 years2024
2022
2023
2024
Q1: -4.86 years
Med: 0.0 years
Q3: 0.42 years
Good+25 pts over 3 years
In 2024, the repayment capacity of NIH COTE D'AZUR (0.00) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 2257.40. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
2257.404
Interest coverage (2024)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable 1.5-3 : Acceptable < 1.5 : Risk
-0.031
Liquidity indicators evolution NIH COTE D'AZUR
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
2051.167
6465.94
3454.441
4901.509
3881.222
2393.014
3950.571
3449.312
3746.359
2257.404
Interest coverage
0.0
0.0
0.0
0.0
-0.009
-3.329
-0.971
-1.32
-0.847
-0.031
Sector positioning
Liquidity ratio
2257.42024
2022
2023
2024
Q1: 116.12
Med: 259.63
Q3: 922.99
Excellent
In 2024, the liquidity ratio of NIH COTE D'AZUR (2257.40) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
-0.03x2024
2022
2023
2024
Q1: -3.47x
Med: 0.0x
Q3: 0.32x
Average+25 pts over 3 years
In 2024, the interest coverage of NIH COTE D'AZUR (-0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 327 days. Excellent situation: suppliers finance 327 days of the operating cycle (retail model). Overall, WCR represents 1 days of revenue, i.e. 2 k€ to permanently finance.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
2 370 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
327 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR in days of revenue (2024)
?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management
1 j
WCR and payment terms evolution NIH COTE D'AZUR
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
2 370 €
Inventory turnover (days)
0
0
0
0
0
0
0
0
0
0
Customer payment term (days)
0
0
0
0
0
0
0
0
0
0
Supplier payment term (days)
1714
485
1284
642
541
2349
223
471
350
327
Positioning of NIH COTE D'AZUR in its sector
Comparison with sector Supports juridiques de programmes
Valuation estimate
Based on 80 transactions of similar company sales
(all years),
the value of NIH COTE D'AZUR is estimated at
419 641 €
(range 150 898€ - 1 032 084€).
The price/revenue ratio is 0.28x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate. Medium reliability: estimate to be confirmed with in-depth analysis.
Estimated enterprise value2024
80 tx
150k€419k€1032k€
419 641 €Range: 150 898€ - 1 032 084€
NAF 5 all-time
Valuation method used
Revenue Multiple
1 500 000 €
×
0.28x
=419 642 €
Range: 150 899€ - 1 032 085€
Only this financial indicator is available for this company.
How is this estimate calculated?
This estimate is based on the analysis of 80 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Supports juridiques de programmes)
Compare NIH COTE D'AZUR with other companies in the same sector:
The headquarters of NIH COTE D'AZUR is located in PARIS (75015), in the department Paris.
Where to find the tax return of NIH COTE D'AZUR ?
The tax return of NIH COTE D'AZUR is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does NIH COTE D'AZUR operate?
NIH COTE D'AZUR operates in the sector Supports juridiques de programmes (NAF code 41.10D). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart